Advertisement
Advertisement
BLCO
Bausch + Lomb Corporation
19.38
USDSponsored
-1.31
-6.33%
Nov 20, 15:59 UTC -5
Closed
After-Market
19.39
+0.01
+0.03%
Bausch + Lomb Corporation (BLCO) Earnings
BLCO Earnings Reports
Positive Surprise Ratio
BLCO beat 14 of 18 last estimates.
78%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Bausch + Lomb Corporation earnings per share and revenue
On Oct 28, 2026, BLCO reported earnings of 0.34 USD per share (EPS) for Q3 26, beating the estimate of 0.22 USD, resulting in a 53.43% surprise. Revenue reached 1.38 billion, compared to an expected 1.40 billion, with a -1.84% difference. The market reacted with a +15.78% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Freenome, Inc. Common stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.41
Actual
$0.57
Surprise
+38.69%
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
$0.11
Actual
$0.15
Surprise
+32.63%

Auna S.A.
Report Date
Nov 17, 2026 For Q3 26
Estimate
$0.85
Actual
$0.27
Surprise
-68.34%
Park Dental Partners, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.30
Actual
$0.56
Surprise
+86.27%

LifeMD, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.11
Surprise
+23.77%

Ainos, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-Actual
-$0.25
Surprise
-

Lifeward Ltd. Ordinary Shares
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.83
Actual
-$1.32
Surprise
-57.82%

SeaStar Medical Holding Corporation Common Stock
Report Date
Nov 11, 2026 For Q3 26
Estimate
-$0.93
Actual
-$1.03
Surprise
-10.24%

IceCure Medical Ltd. Ordinary Shares
Report Date
Nov 18, 2026 For Q3 26
Estimate
-$1.18
Actual
-$0.40
Surprise
+66.19%

20/20 Biolabs, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+15.97%
FAQ
What were Bausch + Lomb Corporation's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Bausch + Lomb Corporation reported EPS of $0.34, beating estimates by 53.43%, and revenue of $1.38B, -1.84% below expectations.
How did the market react to Bausch + Lomb Corporation's Q3 2026 earnings?
The stock price moved up 15.78%, changed from $17.62 before the earnings release to $20.40 the day after.
When is Bausch + Lomb Corporation expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Bausch + Lomb Corporation's next earnings report?
Based on --
analysts, Bausch + Lomb Corporation is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.